In an effort to support global initiatives to contain the spread of the new coronavirus (COVID-19), the Academy is presenting Spring 2020 events through online platforms and some of our previously scheduled events are being postponed to a later date. Please check our events listing for the latest information and contact our Customer Service team with any additional questions. For Academy programs and resources about COVID-19, click here.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

Annals

Strategies for Engineered Negligible Senescence

Edited by Edited by Aubrey D.N.J. de Grey (University of Cambridge, Cambridge, United Kingdom)
Strategies for Engineered Negligible Senescence

Published: June 2004

Volume 1019

Learn More

This volume focuses squarely on the fact that, as a result of a wide range of advances over recent years, increasingly many specialists studying the biology of aging are revising their traditional view that mammalian aging will remain essentially immutable for many decades to come. This is exemplified by three carefully argued analyses of the current state of biomedical gerontology published recently by a variety of experts in fields including most major aspects of mammalian aging. We are therefore at an unprecedented turning point in the study of aging, in which the curiosity-driven, exploratory research that has justifiably monopolized the field until now can at last be legitimately accompanied by goal-directed, biotechnological efforts, rationally designed on the basis of solid scientific knowledge. The purpose of this volume is to consolidate that advance by making those at the forefront of each aspect of aging and its control more aware of each other's work and by drawing attention to the comprehensiveness, and therefore the potential efficacy, of foreseeable antiaging biotechnology.